Medical Device Cybersecurity Testing Services Market

Software represents 46.5% of 2026 product-type revenue, while hospital settings account for 28.0%; monitoring applications capture 31.0% share. Recurring demand depends on traceable regulatory evidence and lifecycle testing, although different national documentation routes increase validation cost and delivery time.